Skip to main content

Invest in the Future of
Intelligent Health

The Investment Opportunity

One ecosystem. Multiple self-contained opportunities.

hoopoe holding is more than a health company, it is a governed, AI-enabled health infrastructure connecting physical clinics, digital platforms, telehealth, homecare, and supply chains into one intelligent network.

We operate under DIFC regulatory standards and KPMG-validated projections, giving institutional investors the rare blend of scalability and capital protection.

Each new city or vertical is launched through an independent Special Purpose Vehicle (SPV), ensuring risk isolation, transparent accounting, and equity clarity.

A Structure Built for
Institutional Confidence

Each SPV is independently audited, legally ring-fenced, and structured under a governed capital release model, investor funds move through escrow-based stages, linked to verified operational milestones.

hoopoe holding (DIFC HQ)

Purpose: IP, governance, licensing, and consolidated oversight

Investor Benefit: Transparency and unified reporting

Highly Liquid Investment

Purpose: Each region (MENA, US, Canada, EU, APAC)

Investor Benefit: Geographic diversification and legal protection

Vertical SPVs

Purpose: Clinics, CRM/EMR, telehealth, homecare, pharma

Investor Benefit: Targeted exposure to proven verticals

Regional SPVs

Purpose: Revenue-producing physical operations

Investor Benefit: Tangible asset backing and fast payback

Why hoopoe Is
Low Risk and High Value?

  1. Audited and Verified: All valuations and 5-year forecasts reviewed and signed by KPMG under IFRS methodology.
  2. Proven Operations: Operating profitably in Dubai, with over 30,000+ client journeys, 45% margins, and sub-18-month payback per franchise.
  3. IP-Backed and Legally Protected: Proprietary CRM (HoopoeSense), telehealth and AI modules, blockchain-based identity and tokenization, all registered and protected under Swiss, EUIPO, and DIFC frameworks.
  4. Risk-Isolated Capital:Each SPV protects investor capital from cross-liability. Your exposure is limited to your chosen vehicle.
  5. Exit Optionality:Structured exit mechanisms include buyback, secondary sale, or consolidation into parent IPO, providing clear liquidity paths.

Capital Velocity & Returns

Projections independently validated under KPMG valuation model; detailed data available upon NDA.

Revenue

$3.5 M

Year1

$8.2 M

Year3

$14.7 M

Year5

EBITDA Margin

28%

Year1

41%

Year3

58%

Year5

Cash Flow

Positive in Month 14

Year1

Cumulative $5.6 M

Year3

Cumulative $14 M

Year5

IRR (Avg)

-

Year1

30 – 35 %

Year3

-

Year5

Governance & Risk Shield
We protect capital before we deploy it

This structure provides institutional investors a governed, auditable, and globally compliant investment framework, without the operational risk typical in emerging-market healthcare.

  Regulatory Seat

DIFC (Dubai International Financial Centre)

  Healthcare Licenses

MOHAP / DHA certified

  Arbitration Venue

DIFC Courts

  Audit Partner

KPMG; Valuation under IFRS

  AML / KYC Framework

In line with FATF & DIFC Data Protection Law 2020

  Data & AI Governance

ISO 27001 / EU GDPR / Dubai AI Seal Framework

Global Roll-Out Model

MENA (2024-2026)

100 franchises operational in GCC with central logistics hub in Dubai.

North America (2026-2028)

SPVs across U.S. and Canada, HQ support in Delaware & Toronto.

Europe & APAC (2028-2030)

60 franchises integrated through regional innovation SPVs in Ireland & Singapore.

Exit Strategies

We design exits as carefully as we design entry.
Targeted horizon: 3-5 years average holding period with 30–35 % IRR.

  • Buyback Option

pre-agreed ROI triggers allow parent entity to repurchase equity.

  • Consolidation Pathway

top-performing SPVs merge into parent pre-IPO.

  • Secondary Market Liquidity

DIFC-regulated investor exchange under setup for SPV resale.

  • Strategic Acquisition

comparable exits benchmarked at 5–7× EBITDA (e.g. Valeo Health, Next Health, Restore Hyper Wellness).

Why Now

Timing matters. We are past concept and before saturation.

  • Global shift toward preventive, personalized wellness: market entering exponential growth.
  • hoopoe holding owns the AI + compliance stack that competitors lack.
  • The infrastructure is built: additional capital accelerates replication, not R&D risk.

“hoopoe holding was built to redefine how health ecosystems grow; governed, intelligent, and self-replicating.
Every SPV we create is not a franchise; it’s a living cell in a global organism that learns, earns, and evolves.
For those who invest early, this is not exposure; it’s ownership of a system already alive.”,

Shahriar Shahir Barzegar, Founder & CEO

Join a governed, intelligent healthTech ecosystem

Download Investor DeckBook a Strategy Call

The first health ecosystem engineered as a scalable organism

Digital Products
Franchise & Investment
Ecosystem
Blockchain
hoopoe EMR
Assets
Contact

© 2018 – 2025 hoopoe holding Ltd

WhatsApp